US visa delays for Indians increase due to stricter checks and social media scrutiny More applicants face 221(g) notices, leading to delays and rescheduled appointments. Valid visa holders face ...
Immigration attorney Steven Brown said getting a 221(g)notice after the consular interview has become a new normal for H-1b professionals who are now stuck in their home countries without knowing when ...
Motorists are being routed away from a stretch of Highway 221 as Spartanburg Water crews work to repair a waterline. The work is underway near the intersection of Highway 221 and Elm Street in the ...
SPARTANBURG COUNTY, S.C. (WSPA) – Drivers who frequent a stretch of Highway 221 will have to adjust their route starting Monday. On December 5th, a 20-inch waterline failed under Highway 221 near the ...
On September 12, 2025, Primorsk, Russia’s largest oil export hub in the Baltic region, experienced a significant drone attack. Judge seems skeptical of legal justification for Pentagon's punishment of ...
The Department of Housing and Urban Development (HUD) is investigating whether Colorado providers helped nearly 3,000 people swindle taxpayer money from Uncle Sam, The Post has learned. The ...
Increased social media discussions, particularly on Reddit, highlight H-1B and H-4 visa applicants receiving 221(g) slips after routine questions about social media privacy settings. These slips ...
Starting from December 15, the US State Department broadened the social media vetting process for skilled-worker visas, extending the examination to encompass H-1B professionals and their H-4 ...
RCUS is now resetting its strategy after its Phase 3 STAR-221 was discontinued. This removes domvanalimab for upper-GI cancers as a key catalyst. Instead, they’ll focus now on Casdatifan (AB521), ...
Arcus Biosciences, Inc. (NYSE:RCUS) on Friday announced the discontinuation of the Phase 3 STAR-221 study, being conducted in partnership with Gilead Sciences, Inc. (NASDAQ: GILD), due to futility. • ...
HAYWARD, Calif.--(BUSINESS WIRE)-- Arcus Biosciences, Inc. (RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results